Aplastic anemia due to other external agents
ICD-10 D61.2 is a billable code used to indicate a diagnosis of aplastic anemia due to other external agents.
Aplastic anemia is a rare but serious condition characterized by the failure of the bone marrow to produce sufficient blood cells, leading to pancytopenia (a reduction in red blood cells, white blood cells, and platelets). This specific code, D61.2, is used when aplastic anemia is attributed to external agents, which may include exposure to certain chemicals, drugs, radiation, or infections. The pathophysiology involves damage to hematopoietic stem cells in the bone marrow, resulting in inadequate hematopoiesis. Clinically, patients may present with symptoms such as fatigue, increased susceptibility to infections, and bleeding tendencies due to low platelet counts. Diagnosis typically involves blood tests showing low cell counts and a bone marrow biopsy revealing hypocellularity. Treatment options may include immunosuppressive therapy, bone marrow transplantation, or supportive care, depending on the severity and underlying cause of the condition.
Detailed patient history, exposure history, lab results, and treatment plans.
Patients presenting with unexplained anemia, requiring further investigation into potential external causes.
Ensure thorough documentation of all potential exposures and treatments to support the diagnosis.
Comprehensive cancer treatment history, including chemotherapy or radiation exposure.
Patients with a history of cancer treatment presenting with symptoms of anemia.
Document any prior treatments that could contribute to bone marrow suppression.
Used to evaluate blood cell counts in suspected aplastic anemia.
Document the reason for the CBC and any relevant symptoms.
Hematologists should ensure all relevant lab results are included in the patient's record.
Common causes include exposure to chemicals (like benzene), certain medications, radiation, and viral infections. Identifying the specific cause is crucial for appropriate management.
